bmiMD vs Yucca: which GLP-1 program is better?
bmiMD and Yucca are both telehealth GLP-1 programs, but they differ on price, medications, shipping and how you pay. Here's the side-by-side, with the numbers, so you can pick the right one.
Short answer: bmiMD is our pick in this matchup — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory. Consider Yucca instead if its strength — nationwide 50-state licensing with a low entry price — matters more to you.
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
bmiMD is our pick in this matchup — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory. Consider Yucca instead if its strength — nationwide 50-state licensing with a low entry price — matters more to you.
View Plan: bmiMDBest for: GLP-1 telehealth
Choose bmiMD if…
you want bmiMD's edge — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory.
Best for: All 50 states, low entry price
Choose Yucca if…
you want Yucca's edge — nationwide 50-state licensing with a low entry price.
Cost breakdown
The numbers that actually decide it, side by side.
| | |
|---|---|---|
| Starting price | $119/mo (compounded semaglutide) | From $146/mo |
| Semaglutide | $119/mo (compounded; list $228.60) | Compounded (from ~$146/mo) |
| Tirzepatide | Not a featured product | Compounded (plan-dependent) |
| Offering | Compounded | Compounded |
| Shipping | Included; 'Ready to Ship' in-stock inventory | Free expedited |
| Insurance | Cash | Cash |
On price, bmiMD lists $119/mo (compounded; list $228.60) for compounded semaglutide and Not a featured product for tirzepatide, while Yucca lists Compounded (from ~$146/mo) and Compounded (plan-dependent). Where prices are published, bmiMD is the lower-cost option.
Both are cash-pay compounded programs, so the real decision comes down to price, shipping, pharmacy credentials and support rather than the drug itself.
Full specs, side by side
| | |
|---|---|---|
| Why choose it | GLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory | Nationwide 50-state licensing with a low entry price |
| Watch out for | Semaglutide starts at $119/mo — above the cheapest cash options; tirzepatide isn't featured | Smaller review base than top programs |
| Starting price | $119/mo (compounded semaglutide) | From $146/mo |
| Compounded semaglutide | $119/mo (compounded; list $228.60) | Compounded (from ~$146/mo) |
| Tirzepatide | Not a featured product | Compounded (plan-dependent) |
| GLP-1 + GIP option | Not listed | Yes — compounded tirzepatide (GLP-1/GIP) |
| Offering type | Compounded | Compounded |
| New-patient offer | Sale pricing $119/mo (from $228.60) | Varies |
| Billing model | Monthly plans | Monthly plans |
| What's included | Online medical evaluation, Medication, Shipping | Medical evaluation, Medication, Expedited shipping |
| Lab work | Online intake | Online intake |
| Shipping | Included; 'Ready to Ship' in-stock inventory | Free expedited |
| Refills | Monthly refills | Monthly refills |
| States | US telehealth | All 50 states |
| Pharmacy | US compounding pharmacies | US compounding pharmacies |
| Clinicians | US-licensed prescribers | US-licensed providers |
| Insurance | Cash | Cash |
| Consultation | Online medical intake | Online medical intake |
| Our rating | 8.7 · Very Good | 8.1 · Good |
Medications & formulations
- bmiMD: compounded GLP-1. Not listed
- Yucca: compounded GLP-1. Yes — compounded tirzepatide (GLP-1/GIP)
New to the drugs themselves? Read our plain-language guides to semaglutide and tirzepatide.
Pros & cons
Pros
- Transparent list-vs-sale pricing shown upfront
- Ready-to-ship inventory for fast dispatch
- One clinic for GLP-1 plus peptide and longevity therapies
- No insurance required to start
Cons
- Compounded semaglutide entry ($119/mo) is higher than the cheapest cash programs
- Compounded tirzepatide isn't a featured option
- Compounded products aren't FDA-approved finished drugs
Pros
- Available in all 50 states
- Free expedited shipping
- Low entry price
Cons
- Smaller review base
- Compounded only
Where each one has the edge
We don't tally a winner — that hides the trade-offs. Here's who leads on each dimension and why.
bmiMD: $119/mo (compounded; list $228.60). Yucca: Compounded (from ~$146/mo).
bmiMD offers compounded; Yucca offers compounded.
bmiMD: Included; 'Ready to Ship' in-stock inventory. Yucca: Free expedited.
Comparable pharmacy disclosures.
Both are primarily cash-pay for compounded GLP-1.
Match by your priority
The fastest way to decide: find your top priority, see which program we'd point you to.
If your priority is the lowest published price
If your priority is the best shipping
If your priority is our overall pick
bmiMD vs Yucca: common questions
The bottom line
bmiMD is our pick in this matchup — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory. Choose Yucca only if its strength (nationwide 50-state licensing with a low entry price) matters more to you than price and our overall rating.
How we compare — and how to read this
We compare programs on the factors that actually affect a patient: real price (including whether it's compounded or branded), medications and formulations offered, shipping, pharmacy accreditation and clinician model, insurance stance, and commitment. We name a top pick for most people, but we show the trade-offs in full so you can override it when your priorities or insurance point the other way. Pricing is provider-reported and changes frequently — and compounded-drug availability shifts with FDA shortage status — so always confirm the current details on the provider's own site before enrolling. Affiliate relationships do not change a program's placement. This page is educational and not medical advice; see our disclaimer.
Not sure which one is right for you?
Answer 7 quick questions and we'll match you to a program.
Take the match quiz